Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/21/2003US20030159168 Transgenic animals; genetic engineering; mutants; disease models; modulate gene expression; insertion stem cells into rodents
08/21/2003US20030159167 Insertion of mutant Dna into cells
08/21/2003US20030159166 Collecting antibodies from immunized mouse
08/21/2003US20030159165 Genetic engineering of metalloproteinase; phenotype indicator of bone disorders
08/21/2003US20030159164 Animal feeds
08/21/2003US20030159163 Transgenic animal; animal models; gene expression; skin disorders
08/21/2003US20030159161 Synthetic genes and genetic constructs comprising same I
08/21/2003US20030159160 Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof
08/21/2003US20030159158 Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders
08/21/2003US20030158407 A Fluorescent dyes for labelling biopolymers and cell surface, a conjugated with polynucleotides or nucleotides
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158398 Central nervous system disorders; psychological disorders
08/21/2003US20030158397 From toluene using Pseudomonas
08/21/2003US20030158392 IP-10/Mig receptor designated CXCR3, antibodies, nucleic acids, and methods of use therefor
08/21/2003US20030158390 Protein; Escherichia culture product; genetic engineering; fusion
08/21/2003US20030158388 MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof
08/21/2003US20030158385 Novel fungal lipase
08/21/2003US20030158382 Bactericides; viricides
08/21/2003US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof
08/21/2003US20030158379 A DNA molecules encoding the proteins, used in the treatment of bone, connective tissue, tendon, ligament, wound healing and defects to tissues, animal growth factors, cell differentiation of embryonic and stem cells
08/21/2003US20030158376 Relaxin-like factor and methods and uses thereof
08/21/2003US20030158187 Genetic polymorphisms in the preprotachy kinin gene
08/21/2003US20030158149 Administering a nucleoside or a nucleoside analog, such as (5'-fluoro-5-methyl-beta-arabinofuranosyl-uridine) or salt or prodrug that suppresses the expression of hepatitis B surface or preS1 antigen in the host 100-fold
08/21/2003US20030158144 Antisense modulation of estrogen receptor beta expression
08/21/2003US20030158143 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers
08/21/2003US20030158142 For screening for compounds which affects apoptosis
08/21/2003US20030158141 Comprising virus, non-coding regulatory region of which is replaced by heterologous encoding sequence, wherein function of replaced regulatory region is dependent upon secondary structure and wherein encoding sequence has said function
08/21/2003US20030158140 Splicing as target for identifying new active substances
08/21/2003US20030158138 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide
08/21/2003US20030158137 Gene directed enzyme prodrug theraphy (gdept) for cell ablation
08/21/2003US20030158136 Materials and methods relating to immune responses to fusion proteins
08/21/2003US20030158135 Derived from staphylococcal genes; use of the polynucleotides as oligonucleotide primers or probes for detecting Staphylococcal strains that are resistant to streptogramin A or streptogramin B and related compounds in biological sample
08/21/2003US20030158134 Use of HIV Tat protein or polynucleotide, HIV Nef protein or polynucleotide, HIV Tat protein or polynucleotide linked to HIV Nef protein or polynucleotide and HIV gpl20 protein or polynucleotide in manufacture of vaccine against hiv
08/21/2003US20030158133 Use of such inhibitors or activators in treatment of dilated cardiomyopathy, pulmonary hypertension and/or other medical conditions related to PDE3 effects on cAMP levels in different intracellular compartments
08/21/2003US20030158131 DNA vectors containing mutated HIV proviruses
08/21/2003US20030158129 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
08/21/2003US20030158105 Determining polypeptide sequence of at least one Bcr-Abl polypeptide expressed by the human cancer cell and comparing the polypeptide sequence of the Bcr-Abl polypeptide expressed by the human cancer cell to the Bcr-Abl polypeptide sequence
08/21/2003US20030158104 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030158100 For use in therapy
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158092 For therapy of glycoprotein aberration disorders (e.g., cystic fibrosis), including gene therapy
08/21/2003US20030158085 For diagnosis and therapy of pancreatic disorders, particularly type I diabetes
08/21/2003US20030158081 Genetic polymorphisms in the human HMG-CoA reductase gene and their use in diagnosis and treatment of diseases
08/21/2003US20030158070 For use in cleaning formulations
08/21/2003US20030157731 Analyte assay using particulate labels
08/21/2003US20030157718 Expression of heterologous genes from an IRES translational cassette in retroviral vectors
08/21/2003US20030157717 Linear DNA fragments for gene expression
08/21/2003US20030157716 Recombinational cloning using nucleic acids having recombination sites
08/21/2003US20030157715 Controlling activity of chromatin resopnsive element (CRE); gene expression inhibition; gene therapy; forensic; animal husbandry
08/21/2003US20030157713 Anchorage-dependent cell for propagating and measuring cytotoxic activity of lymphocyte; antitumor agents
08/21/2003US20030157711 STAT3 activated stem cell
08/21/2003US20030157704 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
08/21/2003US20030157703 Recombinant herpesvirus of turkeys and use thereof
08/21/2003US20030157700 Preparing microarray wafers for use in high throughput assay
08/21/2003US20030157695 Marine actinomycete taxon for drug and fermentation product discovery
08/21/2003US20030157693 Cell lines with latent immunodeficiency virus and methods of use thereof
08/21/2003US20030157692 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof
08/21/2003US20030157691 Producing genetically engineered retrovirus comprising small interfering RNA (SiRNA) for prevention and treatment of human lymphadenopathy associated viral diseases
08/21/2003US20030157689 Plasmid capable of-directly transfecting cell and expressing nidovirales virus; gene therapy; veterinary medicine; genetic vaccines; immunotherapy
08/21/2003US20030157688 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
08/21/2003US20030157687 Comprises nucleotide sequences coding enzyme inhibitor (TIMP-4) for treatment of arthritis, cancer and scarring
08/21/2003US20030157685 Comprises nucleotide sequences coding retinoblastoma-interacting myosin-like gene (RIM), serine protease (OMI) and oncogene protein (NMI) for use as anticarcinogenic/antiproliferative agents
08/21/2003US20030157684 Microbial B-glucuronidase genes, gene production and uses thereof
08/21/2003US20030157682 Preparing preferential amino acid sequences in vitro; detecting restriction fragment length polymorphisms
08/21/2003US20030157678 Mitogenic oxygenases
08/21/2003US20030157677 Comprises kluyveromyces polypeptide with oxidoreductase activity for generation of 4-haloacetoacetate ester and 4-halo-3- hydroxybutyrate ester
08/21/2003US20030157674 Process for the biological production of 1,3-propanediol with high titer
08/21/2003US20030157673 Genes involved in cyclododecanone degradation pathway
08/21/2003US20030157672 Nitrilase from rhodococcus rhodochrous ncimb 11216
08/21/2003US20030157665 Heat-stable D-aminoacylase
08/21/2003US20030157664 Comprises genetically engineered, stable and functional oxidoreductase (FDH) for preparing chiral compounds such as amino acids
08/21/2003US20030157662 Compositions and methods for recombinational cloning of nucleic acid molecules
08/21/2003US20030157661 De novo synthesized plasmid, methods of making and use thereof
08/21/2003US20030157660 Non-M, non-O HIV-1 strains, fragments and uses
08/21/2003US20030157659 Proteins isolated from cyanobacteria
08/21/2003US20030157658 Polypeptides having beta-1,4-GalNAc transferase activity
08/21/2003US20030157657 Invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an alpha 2,3-and an alpha 2,8- activity; glycosyltransferases obtained from Campylobacter species, including C.jejuni
08/21/2003US20030157656 Invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an alpha 2,3-and an alpha 2,8- activity; glycosyltransferases obtained from Campylobacter species, including C.jejuni
08/21/2003US20030157655 Invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an alpha 2,3-and an alpha 2,8- activity; glycosyltransferases obtained from Campylobacter species, including C.jejuni
08/21/2003US20030157654 Biosynthesis of enediyne compounds by manipulation of C-1027 gene pathway
08/21/2003US20030157650 Recombinant P. vivax merozoite protein-1 p42 vaccine
08/21/2003US20030157649 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003US20030157648 Membrane binding polypeptides derived from urogenital and placenta tissue for monitoring and detecting modulators of ligand bind activity; drug screening
08/21/2003US20030157647 Comprises calcium/glutamate receptor chimera comprising extracellular domain of G-protein coupled membrane protein for treating nervous system disorders
08/21/2003US20030157643 Synthetic nucleic acids from aquatic species
08/21/2003US20030157642 Bacillus genetically engineeered for improved expression of secretion factor G (SECG) and heterologous proteins
08/21/2003US20030157641 Polycistronic expression of antibodies
08/21/2003US20030157640 Genetically engineered yeast cell comprising G-protein coupled receptors/kinases and luminescent reporter molecule for monitoring signal transduction pathways
08/21/2003US20030157639 Comprises genetically engineered eotaxin mediated cytokine receptor (CCR3) with reduced internalized and/or kinase mediated phosphorylation; antiinflammatory agents
08/21/2003US20030157638 Comprises microbiocidal protein for treating ear and vision defects; contraceptives
08/21/2003US20030157636 Methylotrophic bacterium for the production of recombinant proteins and other products
08/21/2003US20030157633 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders
08/21/2003US20030157632 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157631 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157630 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157629 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157628 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157626 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157624 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 ... 4023